National Institutes of Health: Difference between revisions
mNo edit summary |
m Fixed date format error. Updated refs. |
||
| Line 59: | Line 59: | ||
On the 10 June 2011, the OIG published its results from an audit of a contract between the National Institute of Allergy and Infectious Diseases (NIAID) and the University of California at San Francisco, which read in part:<ref>{{REFweb | On the 10 June 2011, the OIG published its results from an audit of a contract between the National Institute of Allergy and Infectious Diseases (NIAID) and the University of California at San Francisco, which read in part:<ref>{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2011-06 | ||
| title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-15416 With the University of California at San Francisco Audit (A-03-10-03120) | |title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-15416 With the University of California at San Francisco Audit (A-03-10-03120) | ||
| url=http://oig.hhs.gov/oas/reports/region3/31003120.pdf | |url=http://oig.hhs.gov/oas/reports/region3/31003120.pdf | ||
| accessdate=2011-06-25 | |accessdate=2011-06-25 | ||
}}</ref> | }}</ref> | ||
| Line 84: | Line 84: | ||
On the 21 September 2011, the OIG published it's results from two separate audits of NIAID contracts with Avecia Biologics Limited and NexBio, Inc. The reports read in part:<ref>{{REFweb | On the 21 September 2011, the OIG published it's results from two separate audits of NIAID contracts with Avecia Biologics Limited and NexBio, Inc. The reports read in part:<ref>{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2011-09 | ||
| title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-3-0052 With Avecia Biologics Limited | |title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-3-0052 With Avecia Biologics Limited | ||
| url=http://oig.hhs.gov/oas/reports/region3/31003117.pdf | |url=http://oig.hhs.gov/oas/reports/region3/31003117.pdf | ||
| accessdate=2011-10-09 | |accessdate=2011-10-09 | ||
}}</ref><ref>{{REFweb | }}</ref><ref>{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2011-09 | ||
| title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN266-2006-00015C With NexBio, Inc. | |title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN266-2006-00015C With NexBio, Inc. | ||
| url=http://oig.hhs.gov/oas/reports/region3/31003119.pdf | |url=http://oig.hhs.gov/oas/reports/region3/31003119.pdf | ||
| accessdate=2011-10-09 | |accessdate=2011-10-09 | ||
}}</ref> | }}</ref> | ||
| Line 136: | Line 136: | ||
On the 31 October 2011, the OIG published it's results from an audit of a contract between NIAID and the EMMES Corporation, which read in part:<ref>{{REFweb | On the 31 October 2011, the OIG published it's results from an audit of a contract between NIAID and the EMMES Corporation, which read in part:<ref>{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2011-10 | ||
| title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN272-2008-00013C with the EMMES Corporation (A-03-10-03115) | |title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN272-2008-00013C with the EMMES Corporation (A-03-10-03115) | ||
| url=http://oig.hhs.gov/oas/reports/region3/31003115.pdf | |url=http://oig.hhs.gov/oas/reports/region3/31003115.pdf | ||
| accessdate=2011-09-11 | |accessdate=2011-09-11 | ||
}}</ref> | }}</ref> | ||
| Line 165: | Line 165: | ||
On the 14 September 2012, the OIG published it's results from two separate audits of NIAID contracts with PPD Development, LP. The reports read in part:<ref>{{REFweb | On the 14 September 2012, the OIG published it's results from two separate audits of NIAID contracts with PPD Development, LP. The reports read in part:<ref>{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2012-09 | ||
| title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN266-2005-00022C With PPD Development, LP (Audit A-03-10-03118) | |title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN266-2005-00022C With PPD Development, LP (Audit A-03-10-03118) | ||
| url=http://oig.hhs.gov/oas/reports/region3/31003118.pdf | |url=http://oig.hhs.gov/oas/reports/region3/31003118.pdf | ||
| accessdate=2012-09-26 | |accessdate=2012-09-26 | ||
}}</ref><ref>{{REFweb | }}</ref><ref>{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2012-09 | ||
| title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-30068 With PPD Development, LP (Audit A-03-10-03116) | |title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-30068 With PPD Development, LP (Audit A-03-10-03116) | ||
| url= http://oig.hhs.gov/oas/reports/region3/31003116.pdf | |url= http://oig.hhs.gov/oas/reports/region3/31003116.pdf | ||
| accessdate=2011-09-26 | |accessdate=2011-09-26 | ||
}}</ref> | }}</ref> | ||
| Line 220: | Line 220: | ||
== Office of Inspector General (OIG) investigations of NICHD commercial partnerships == | == Office of Inspector General (OIG) investigations of NICHD commercial partnerships == | ||
On the 17 October 2011, the OIG published it's results from an audit of a contract between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and Westat, Inc., which read in part:<ref>{{REFweb | On the 17 October 2011, the OIG published it's results from an audit of a contract between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and Westat, Inc., which read in part:<ref name="A-03-10-03106">{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2011-10 | ||
| title=Appropriations Funding for Eunice Kennedy Shriver National Institute of Child Health and Human Development Contract HHSN275-03-3345 With Westat, Inc. Audit (A-03-10-03106) | |title=Appropriations Funding for Eunice Kennedy Shriver National Institute of Child Health and Human Development Contract HHSN275-03-3345 With Westat, Inc. Audit (A-03-10-03106) | ||
| url=http://oig.hhs.gov/oas/reports/region3/31003106.pdf | |url=http://oig.hhs.gov/oas/reports/region3/31003106.pdf | ||
| accessdate=2011-11-20 | |accessdate=2011-11-20 | ||
}}</ref> | }}</ref> | ||
| Line 245: | Line 245: | ||
}} | }} | ||
Background information:<ref | Background information:<ref name="A-03-10-03106"/> | ||
{{Citation | {{Citation | ||
| Title= | |Title= | ||
| Text=On November 1, 2002, NICHD awarded contract HHSN275-03-3345 (the Contract), totaling $164.7 million, to Westat, Inc. (Westat), in Rockville, Maryland. The Contract required Westat to establish an international pediatric and perinatal HIV studies network-coordinating center to maintain, coordinate, and manage a network of clinical centers. These clinical centers, under subcontracts with Westat, conducted research on the treatment, prevention, diagnosis, epidemiology, and natural history of HIV infection and disease in pediatric, adolescent, and maternal patient populations. | |Text=On November 1, 2002, NICHD awarded contract HHSN275-03-3345 (the Contract), totaling $164.7 million, to Westat, Inc. (Westat), in Rockville, Maryland. The Contract required Westat to establish an international pediatric and perinatal HIV studies network-coordinating center to maintain, coordinate, and manage a network of clinical centers. These clinical centers, under subcontracts with Westat, conducted research on the treatment, prevention, diagnosis, epidemiology, and natural history of HIV infection and disease in pediatric, adolescent, and maternal patient populations. | ||
| Author= | |Author= | ||
| Source | |Source= | ||
}} | }} | ||
| Line 269: | Line 257: | ||
On the 26 October 2011, the OIG published it's results from an audit of a contract between the National Institute on Drug Abuse (NIDA) and Charles River Laboratories, Inc., which read in part:<ref>{{REFweb | On the 26 October 2011, the OIG published it's results from an audit of a contract between the National Institute on Drug Abuse (NIDA) and Charles River Laboratories, Inc., which read in part:<ref>{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2011-10 | ||
| title=Appropriations Funding for National Institute on Drug Abuse Contract HHSN271-2007-00009C with Charles River Laboratories, Inc. (A-03-10-03104) | |title=Appropriations Funding for National Institute on Drug Abuse Contract HHSN271-2007-00009C with Charles River Laboratories, Inc. (A-03-10-03104) | ||
| url=http://oig.hhs.gov/oas/reports/region3/31003104.pdf | |url=http://oig.hhs.gov/oas/reports/region3/31003104.pdf | ||
| accessdate=2011-11-22 | |accessdate=2011-11-22 | ||
}}</ref> | }}</ref> | ||
| Line 320: | Line 308: | ||
On the 20 December 2011, the OIG published a report critical of the NIH's administration of the Clinical and Translational Science Awards (CTSA) program.<ref>{{REFweb | On the 20 December 2011, the OIG published a report critical of the NIH's administration of the Clinical and Translational Science Awards (CTSA) program.<ref>{{REFweb | ||
| last= | |last= | ||
| first= | |first= | ||
| date= | |date=2011-12 | ||
| title=NIH Administration of the Clinical and Translational Science Awards Program (Report OEI-07-09-00300) | |title=NIH Administration of the Clinical and Translational Science Awards Program (Report OEI-07-09-00300) | ||
| url=http://oig.hhs.gov/oei/reports/oei-07-09-00300.pdf | |url=http://oig.hhs.gov/oei/reports/oei-07-09-00300.pdf | ||
| accessdate=2011-12-22 | |accessdate=2011-12-22 | ||
}}</ref> The report read in part: | }}</ref> The report read in part: | ||
| Line 348: | Line 336: | ||
== Weird Science == | == Weird Science == | ||
"NIH video reveals the science behind yoga"<ref>{{REFweb | "NIH video reveals the science behind yoga"<ref>{{REFweb | ||
| last=NIH | |last=NIH | ||
| first= | |first= | ||
| date= | |date=2012-08 | ||
| title=NIH video reveals the science behind yoga | |title=NIH video reveals the science behind yoga | ||
| url=http://www.nih.gov/news/health/aug2012/nccam-01.htm | |url=http://www.nih.gov/news/health/aug2012/nccam-01.htm | ||
| accessdate=2012-08-02 | |accessdate=2012-08-02 | ||
}}</ref> | }}</ref> | ||
| Line 376: | Line 364: | ||
== Continuing advocating for more circumcision == | == Continuing advocating for more circumcision == | ||
From a National HIV Vaccine Awareness Day statement dated 18 May 2011 by Anthony S. Fauci, M.D., Director of NIAID (emphasis added):<ref>{{REFweb | From a National HIV Vaccine Awareness Day statement dated 18 May 2011 by Anthony S. Fauci, M.D., Director of NIAID (emphasis added):<ref>{{REFweb | ||
| last=Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health | |last=Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health | ||
| first= | |first= | ||
| date= | |date=2011-05 | ||
| title=National HIV Vaccine Awareness Day May 18, 2011 Statement | |title=National HIV Vaccine Awareness Day May 18, 2011 Statement | ||
| url=http://www.niaid.nih.gov/news/newsreleases/2011/Pages/HVAD2011.aspx?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+aidsgovnews+%28AIDS.gov+News+and+Events%29 | |url=http://www.niaid.nih.gov/news/newsreleases/2011/Pages/HVAD2011.aspx?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+aidsgovnews+%28AIDS.gov+News+and+Events%29 | ||
| accessdate=2011-06-25 | |accessdate=2011-06-25 | ||
}}</ref> | }}</ref> | ||